Ambrisentan is indicated for the treatment of pulmonary
arterial hypertension (PAH) (WHO Group 1):
To improve exercise ability and delay clinical worsening.
In combination with tadalafil to reduce the risks of disease
progression and hospitalization for worsening PAH, and to improve exercise
ability.
Studies establishing effectiveness included predominantly patients with WHO Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (60%) or PAH associated with connective tissue diseases (34%).
20's pack : ৳
802.53 (Unit Price : ৳
40.13)